-
Mashup Score: 1
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2021 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 4
Largest study to date to report detailed findings by blood cancer and treatment type Non-Hodgkin lymphoma patients less likely to have detectable antibodies Among leukemia patients, those with chronic lymphocytic leukemia most likely to be seronegative Multiple myeloma patients had higher rates of antibodies compared to other blood cancers LLS experts say vaccination offers protection to most…
Source: lls.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies [Jul 22, 2021] @LLSusa https://t.co/cp98Y5ia7C #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387 https://t.co/WHV0oo80ee
-
-
Mashup Score: 4
Largest study to date to report detailed findings by blood cancer and treatment type Non-Hodgkin lymphoma patients less likely to have detectable antibodies Among leukemia patients, those with chronic lymphocytic leukemia most likely to be seronegative Multiple myeloma patients had higher rates of antibodies compared to other blood cancers LLS experts say vaccination offers protection to most…
Source: lls.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies [Jul 22, 2021] @LLSusa https://t.co/cp98Y5ia7C #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387 https://t.co/abuhpeUUGz
-
-
Mashup Score: 0
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2021 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Antibody response to SARS-CoV-2 vaccines in patients w/ hematologic malignancies {In Press, Journal Pre-proof} [Jul 22, 2021] @GreenbergerLee et al. @LLSusa @Cancer_Cell https://t.co/E1NBtDhYK1 #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387
-
-
Mashup Score: 1
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2021 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Antibody response to SARS-CoV-2 vaccines in patients w/ hematologic malignancies {In Press, Journal Pre-proof} [Jul 22, 2021] @GreenbergerLee et al. @LLSusa @Cancer_Cell https://t.co/E1NBtDhYK1 #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387 https://t.co/0PskC1zotk
-
-
Mashup Score: 1
Largest study to date to report detailed findings by blood cancer and treatment type Non-Hodgkin lymphoma patients less likely to have detectable antibodies Among leukemia patients, those with chronic lymphocytic leukemia most likely to be seronegative Multiple myeloma patients had higher rates of antibodies compared to other blood cancers LLS experts say vaccination offers protection to most…
Source: lls.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies [Jul 22, 2021] @LLSusa https://t.co/cp98Y5ia7C #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387 https://t.co/F2Q3KR8MHQ
-
-
Mashup Score: 19
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2021 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Antibody response to SARS-CoV-2 vaccines in patients w/ hematologic malignancies {In Press, Journal Pre-proof} [Jul 22, 2021] @GreenbergerLee et al. @LLSusa @Cancer_Cell https://t.co/E1NBtDhYK1 #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387
-
-
Mashup Score: 3
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies Largest study to date to report detailed findings by blood cancer and treatment type Non-Hodgkin lymphoma patients less likely to have detectable antibodies Among leukemia patients, those with chronic lymphocytic leukemia most likely to be…
Source: lls.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies [Jul 22, 2021] @LLSusa https://t.co/cp98Y5ia7C #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387
-
-
Mashup Score: 1
About ScienceDirectRemote accessShopping cartAdvertiseContact and supportTerms and conditionsPrivacy policyWe use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of cookies.Copyright © 2021 Elsevier B.V. or its licensors or contributors. ScienceDirect ® is a registered trademark of Elsevier B.V.ScienceDirect ® is a registered…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet-
Antibody response to SARS-CoV-2 vaccines in patients w/ hematologic malignancies {In Press, Journal Pre-proof} [Jul 22, 2021] @GreenbergerLee et al. @LLSusa @Cancer_Cell https://t.co/E1NBtDhYK1 #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387 https://t.co/ulpWlDociD
-
-
Mashup Score: 1
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies Largest study to date to report detailed findings by blood cancer and treatment type Non-Hodgkin lymphoma patients less likely to have detectable antibodies Among leukemia patients, those with chronic lymphocytic leukemia most likely to be…
Source: lls.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Study from The Leukemia & Lymphoma Society Shows COVID-19 Vaccine Is Safe But 25% Of Blood Cancer Patients Do Not Produce Detectable Antibodies [Jul 22, 2021] @LLSusa https://t.co/cp98Y5ia7C #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387 https://t.co/9wfmelkYcF
-
Antibody response to SARS-CoV-2 vaccines in patients w/ hematologic malignancies {In Press, Journal Pre-proof} [Jul 22, 2021] @GreenbergerLee et al. @LLSusa @Cancer_Cell https://t.co/E1NBtDhYK1 #COVID19nCancer #COVID19Vaccine #CCC19 #CLLsm #leusm #lymsm #mmsm #mpnsm #NCT04794387 https://t.co/3FzixtHDU0